Healthmine recently shared an article written by AIS Health with support from EVP of Consulting & Professional Services, Melissa Smith. The article discusses paused measures that may have inflated 2022 Star Ratings, but also offers important strategies plans can utilize as they enter the next measurement year.
To read more, click here.
NeuroFlow, which develops technology and services for behavioral health integration, is now available to 42,000 employees of Thomas Jefferson University and Jefferson Health.
The initiative will focus on increasing access to behavioral health resources and daily self-care for employees, faculty and students across Jefferson’s university, clinical and corporate services settings. NeuroFlow’s evidenced-based platform will engage with healthcare professionals by providing tailored content, regular surveys, exercises, and crisis resources, depending on individual needs.
Neuroflow, which was originally implemented in patient care settings by Jefferson Health’s clinical staff in 2019 and offered to all Thomas Jefferson University students this past summer, tracks outcomes and provides remote support with a care management system to close the gap between mental and physical health.
The Covid-19 pandemic served as a catalyst for mental health awareness while also increasing rates of burnout among healthcare workers. As a result, Jefferson recognized an opportunity to expand the use of technology to support its employee population. Leaders from across the organization, including those in clinical and academic settings and the human resources department, are working toward a larger “holistic health” program being introduced to faculty and employees over the next several months.
To read more, click here.
CB Insights published a list ranking the 150 top digital health companies for 2021. It’s the third year it has compiled the list.
The report named General Catalyst the most active investor of the year. Since 2020, General Catalyst has participated in 33 deals for digital health companies included in the ranking this year, including deals for Cityblock Health, Commure, Olive, and Transcarent. Tiger Global Management and Andreessen Horowitz had 20 and 15 deals, respectively.
Cityblock Health has raised the most funding of any digital health company on the list, having raised $891 million across eight rounds since 2018.
To read more, click here.
Breakout Ventures, which invests in bioscience entrepreneurs, announced the close of its oversubscribed second fund with $112.5 million in commitments. Its Fund II received strong support from existing limited partners including Dolby Family Ventures, Thiel Foundation, GRIDS Capital, S Cubed Capital and deep tech investors Chris & Crystal Sacca, Tony Fadell, Zack Bogue and Matt Ocko.
Breaking Ventures will continue to back seed stage through Series A stage companies in creative biosciences.
So far. Fund II has made a few investments, including CellChorus which focuses on single-cell analysis, and Parthenon Therapeutics, which is reprogramming the tumor microenvironment.
To read more, click here.
Whitecap Venture Partners announced its new fund, Whitecap V, with commitments of $110.2 million. Whitecap is one of the longest running early stage technology investors in Canada. The new fund will invest in medtech startups as well as b2b software companies across Canada.
Although the firm has focused invesment on Series A stage companies, its new fund will allocate more capital to seed and pre-seed funding rounds.
To read more, click here.
Picture: akindo, Getty Images
